Overview

A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C

Status:
Withdrawn

Trial end date:
2010-10-01

Target enrollment:

Participant gender:

Summary

This study seeks to evaluate the safety and efficacy of taking fluvastatin along with peginterferon alfa in previous partial responders with genotype 1 HCV.

Phase:

Phase 2

Details

Lead Sponsor:

University of Chicago

Treatments:

Fluvastatin
Interferon-alpha
Interferons
Peginterferon alfa-2a
Ribavirin